Loading
Loading…
New: tenders and results on WhatsApp
New: Find tenders, results and companies on WhatsApp, by text or voice note
New: tenders and results on WhatsApp
New: Find tenders, results and companies on WhatsApp, by text or voice note
Loading…
Tender ID
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
| # | Company | Amount | Rank | Status |
|---|---|---|---|---|
| 1 | L1₹20.9 LAdmitted-Finance SHOP NO 110A PRESTIGE POINT PREMISES CO OPERATIVE SOCIETY 283 SHUKRAWAR PETH PUNE PUNE MAHARASHTRA 411002 | PUNE | MAHARASHTRA | 411002 | L1 | Admitted-Finance | |
| 2 | L2₹72.5 L+₹51.6 L (247.0%)Admitted-Finance SHOP NO 27 GR FLR BIZZBAY S NO 29 1 1 2 3 29 2 TO 6 PROP NO O E 01 03100069 NIBM ROAD KONDHAWA KHURD PUNE MAHARASHTRA 411048 | PUNE | MAHARASHTRA | 411048 | L2 | Admitted-Finance | |
| 3 | L3₹85.2 L+₹64.3 L (307.8%)Admitted-Finance SHOP NO 1 NAMRATA SOCIETY 248 269 724 GHORPADE PETH GHORPADE PETH PUNE MAHARASHTRA 411042 | PUNE | MAHARASHTRA | 411042 | L3 | Admitted-Finance | |
| 4 | Rejected-Technical OFFICE NO 207 2ND FLOOR EAST END PLAZA EAST END PLAZA VASUNDHARA ENCLAVE NEW DELHI EAST DELHI DELHI 110096 | EAST DELHI | DELHI | 110096 | - | Rejected-Technical Incomplete Document | |
| 5 | Rejected-Technical | - | Rejected-Technical Incomplete Document |
| Sl No | Description | Qty | Unit | Shri Vinayak Pharma L3 | AMBIKA DRUG HOUSE L1 | Arihant Meditech L2 |
|---|---|---|---|---|---|---|
| 1.01 | Multi dose DPI Formoterol 9 mcg + Budesonide 320 mcg Reservoir type Breath actuated DPI | 7,200 | NO | - | - | 40,93,632 ₹45,84,867.84 Lowest |
| 1.02 | MDI Synchrobreathe inhaler with Formoterol 6 mcg and Budesonide 200 mcg | 6,960 | NO | 26,85,933.6 ₹30,08,245.63 Lowest | - | - |
| 1.03 | MDI Synchrobreathe inhaler with Formoterol 6 mcg and Budesonide 400 mcg | 8,640 | NO | 37,24,185.6 ₹41,71,087.87 Lowest | - | - |
| 1.04 | Autohaler Synchrobreathe Tiotropium 9 mcg 120 dose | 3,600 | NO | 11,99,196 ₹13,43,099.52 Lowest | - | - |
| 1.05 | FDC of Mometasone Furoate 136 mcg + Glycopyronium Bromide eq to 46 mcg and Indacaterol acetate 114 mcg Inhalation power | 3,240 | NO | - | 18,65,916 ₹20,89,825.92 Lowest | 23,81,400 ₹26,67,168 |
Tender Value
₹1.5 Cr
EMD Value
₹4.6 L
Closing Date
10 Jan 2025, 6:00 pmClosed
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
COL SAAJAN JOSHI
AICTS PUNE
CATEGORY I
2024_ARMY_689849_1
PA/AICTS /DGLP/ECHS/LTE/ 12/2024-25
Limited
Suture and related products
Buy
30 days
AICTS
PLEASE REFER TENDER DOCUMENTS
5 documents required · 5 mandatory
₹0
₹4.6 L
Yes
20 Jan 2025
21 Dec 2024
11 Jan 2025
21 Dec 2024
10 Jan 2025
21 Dec 2024
21 Dec 2024 - 9 Jan 2025
Multi dose DPI Formoterol 9 mcg + Budesonide 320 mcg Reservoir type Breath actuated DPI
MDI Synchrobreathe inhaler with Formoterol 6 mcg and Budesonide 200 mcg
MDI Synchrobreathe inhaler with Formoterol 6 mcg and Budesonide 400 mcg
Autohaler Synchrobreathe Tiotropium 9 mcg 120 dose
FDC of Mometasone Furoate 136 mcg + Glycopyronium Bromide eq to 46 mcg and Indacaterol acetate 114 mcg Inhalation power
Arihant Meditech (BID ID -3211353)
Shri Vinayak Pharma (BID ID -3210529)
AMBIKA DRUG HOUSE
Arihant Meditech
stage.html
html • 0.03 MB
tech_bid_open.pdf
tech_eval.pdf
fin_bid_open.pdf
boq_comp_chart.xlsx
xlsx
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.03 MB
Tendernotice_1.pdf
PDF • 0.44 MB
Tenderacceptance.pdf
Tender Documents • 0.40 MB
Manufacturing.xls
Tender Documents • 7.33 MB
BOQ_772209.xls
BOQ • 0.24 MB
RFP.pdf
Tender Documents • 0.74 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .